3 Pharmaceutical Stock Earnings Snapshots

Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) had a loss and missed Wall Street’s expectations, AND came up short on beating the revenue expectation. Adjusted Earnings Per Share increased to $-0.34 in the quarter versus EPS of $-0.49 in the year-earlier quarter. Revenue Rose 32.86% to $4.69 company missed the mean analyst estimate of $-0.31. It missed the average revenue estimate of $5.65 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

SVNT

Agilent Technologies Inc. (NYSE:A) delivered a profit and beat Wall Street’s expectations, BUT came up short on beating the revenue expectation. Adjusted Earnings Per Share decreased 1.28% to $0.77 in the quarter versus EPS of $0.78 in the year-earlier quarter. Revenue Decreased 0.06% to $1.73 billion from the year-earlier quarter.

Agilent Technologies Inc. reported adjusted EPS income of $0.77 per share. By that measure, the company beat the mean analyst estimate of $0.67. It missed the average revenue estimate of $1.74 billion.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

A

WuXi PharmaTech (Cayman) Inc. (NYSE:WX) delivered a profit and beat Wall Street’s expectations, AND beat the revenue expectation. Adjusted Earnings Per Share increased 6.06% to $0.35 in the quarter versus EPS of $0.33 in the year-earlier quarter. Revenue Rose 11.75% to $131.9 million from the year-earlier quarter.

WuXi PharmaTech (Cayman) Inc. reported adjusted EPS income of $0.35 per share. By that measure, the company beat the mean analyst estimate of $0.31. It beat the average revenue estimate of $130.02 million.

NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!

WX

Stocks with improving earnings metrics are worthy of your extra attention. In fact, “E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our CHEAT SHEET investing framework for this very reason. Don’t waste another minute – click here and get our CHEAT SHEET stock picks now.